1. Home
  2. ULH vs PRME Comparison

ULH vs PRME Comparison

Compare ULH & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Logistics Holdings Inc.

ULH

Universal Logistics Holdings Inc.

HOLD

Current Price

$17.91

Market Cap

455.9M

Sector

Industrials

ML Signal

HOLD

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$3.21

Market Cap

526.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ULH
PRME
Founded
1932
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
455.9M
526.0M
IPO Year
2004
2022

Fundamental Metrics

Financial Performance
Metric
ULH
PRME
Price
$17.91
$3.21
Analyst Decision
Buy
Analyst Count
0
14
Target Price
N/A
★ $7.11
AVG Volume (30 Days)
48.1K
★ 3.0M
Earning Date
10-22-2026
11-06-2026
Dividend Yield
★ 2.27%
N/A
EPS Growth
N/A
★ 18.18
EPS
★ 0.86
N/A
Revenue
★ $1,461,708,000.00
$4,632,000.00
Revenue This Year
N/A
$90.67
Revenue Next Year
$4.75
$19.46
P/E Ratio
$20.59
★ N/A
Revenue Growth
N/A
★ 55.28
52 Week Low
$11.73
$2.67
52 Week High
$25.80
$6.85

Technical Indicators

Market Signals
Indicator
ULH
PRME
Relative Strength Index (RSI) 49.72 50.31
Support Level $14.82 $3.14
Resistance Level $19.07 $3.56
Average True Range (ATR) 0.90 0.25
MACD 0.00 -0.01
Stochastic Oscillator 55.52 55.35

Price Performance

Historical Comparison
ULH
PRME

About ULH Universal Logistics Holdings Inc.

Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada, and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The firm has three reportable segments, namely contract logistics, intermodal, and trucking. The company generates the key revenue from Contract Logistics, which provides value-added and dedicated transportation services to support inbound and internal logistics requirements of industrial manufacturers and retailers, generally under contractual arrangements of one year or longer. Geographically, the firm generates the majority of its revenue from the United States, followed by Mexico, Canada, and Colombia.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

Share on Social Networks: